Motesanib
Motesanib
Motesanib (pronounced mo-tes-a-nib) is a type of antineoplastic agent used in the treatment of certain types of cancer. It is a small molecule inhibitor that targets multiple receptor tyrosine kinases.
Etymology
The term "Motesanib" is derived from the combination of the words "molecule" and "tyrosine kinase inhibitor". The prefix "Mote-" is derived from "molecule", and "-sanib" is a common suffix for tyrosine kinase inhibitors.
Usage
Motesanib is used in the treatment of various types of cancer, including thyroid cancer, lung cancer, and colorectal cancer. It works by inhibiting the growth of cancer cells and slowing the growth of new blood vessels in tumors.
Side Effects
Common side effects of Motesanib include nausea, vomiting, diarrhea, and fatigue. More serious side effects can include high blood pressure, bleeding, and heart problems.
Related Terms
- Antineoplastic agent
- Small molecule inhibitor
- Receptor tyrosine kinase
- Thyroid cancer
- Lung cancer
- Colorectal cancer
- Nausea
- Vomiting
- Diarrhea
- Fatigue
- High blood pressure
- Bleeding
- Heart problems
External links
- Medical encyclopedia article on Motesanib
- Wikipedia's article - Motesanib
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski